Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Aneurysm IV: Nursing Management

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gut-derived acetate promotes B10 cells with antiinflammatory effects.

JCI insight·2021

Same author

A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancer.

Current oncology (Toronto, Ont.)·2020

Same author

Metastatic colorectal cancer: therapeutic options for treating refractory disease.

Current oncology (Toronto, Ont.)·2019

Same author

Feeding practices of pre-school children and associated factors in Kathmandu, Nepal.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2019

Same author

Substance use among treatment seeking Indian adolescent girls: Are they unique?

Asian journal of psychiatry·2019

Same author

A randomised controlled trial assessing the efficacy of co-phenylcaine nasal spray in flexible transnasal pharyngolaryngoscopy.

Annals of the Royal College of Surgeons of England·2016

Search research articles

Related Experiment Video

Updated: May 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antiplatelet drugs in elective ENT surgery.

J R Savage¹, A Parmar, P J Robinson

¹ENT Department, University of Sherbrooke, Quebec, Canada. Julian.Savage@USherbrooke.ca

The Journal of Laryngology and Otology

|August 16, 2012

Summary

Managing patients on oral antiplatelet drugs before ENT surgery requires risk stratification. Recommendations guide the peri-operative care of high-risk and low-risk patients, especially those with intracoronary stents.

Related Experiment Videos

Last Updated: May 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Area of Science:

Otolaryngology
Cardiology
Pharmacology

Background:

Oral antiplatelet drugs are common in patients undergoing elective Ear, Nose, and Throat (ENT) surgery.
Pre-operative cessation of these medications poses risks, particularly for patients with intracoronary stents.

Purpose of the Study:

To assess current peri-operative management practices for patients on antiplatelet drugs.
To provide evidence-based recommendations for managing these patients.

Main Methods:

An online survey was distributed to the Expert Panel of ENT UK.
The survey was conducted between January 13 and February 15, 2011.

Main Results:

A 55% response rate was achieved from 303 contacted members (167 replies).
78% of respondents were consultants, indicating expert input.

Conclusions:

Patients taking antiplatelet drugs can be categorized into high and low-risk groups based on their indication.
Literature-derived recommendations are provided for managing these distinct patient risk categories.